GLIOBLASTOMA MULTIFORME: A BRIEF LITERATURE REVIEW
Palavras-chave
Downloads
Resumo
The objective of this article is to review the current state of knowledge about glioblastoma multiforme. Gliomas originated in astrocytes can be classified into four types: Pilocytic Astrocytoma, Fibrillary Astrocytoma, Anaplastic Astrocytoma and Glioblastoma Multiforme. Glioblastoma Multiforme is the most malignant and aggressive type of these. The risk factors for this tumor are still poorly understood, but it has been proven that ionizing radiation can be one of them. The diagnosis is made through the analysis of the critical manifestations and with complementary examinations such as computed tomography and magnetic resonance imaging. The treatments used against this type of tumor are maximum tumor resection, radiotherapy, chemotherapy, Tumor-Treating Fields, Bevacizumab, Oncolytic Viruses. Although there are several types of treatment, the prognosis of this tumor remains limited. More studies are needed tob investigate the effectiveness of the treatments used, as well as the access of the general public to these treatments in the public health system.
Biografia do Autor
Universidade de Mogi das Cruzes (UMC).
Referências
DAVIS, Mary Elizabeth. Glioblastoma: Overview of Disease and Treatment. [S. l.], v. 20, n. 5, 2016.
FRANCIPANE, Maria Giovanna; DOURADINHA, Bruno; CHINNICI, Cinzia Maria; RUSSELLI, Giovanna; CONALDI, Pier Giulio; IANNOLO, Gioacchin. Zika virus: A new therapeutic candidate for glioblastoma treatment. International Journal of Molecular Sciences, [S. l.], v. 22, n. 20, 2021 DOI: https://doi.org/10.3390/ijms222010996
GOVINDAN, Aparna; CHAKRABORTI, Shrijeet; MAHADEVAN, Anita; CHICKABASAVAIAH, Yasha T.; SANTOSH, Vani; SHANKAR, S. K. Histopathologic and immunohistochemical profile of spinal glioblastoma: a study of six cases. Brain tumor pathology, Japan, v. 28, n. 4, p. 297–303, 2011 DOI: https://doi.org/10.1007/s10014-011-0041-5
GRITSCH, Simon; BATCHELOR, Tracy T.; GONZALEZ, Castro L. Nicolas. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system. Cancer, United States, v. 128, n. 1, p. 47–58, 2022 DOI: https://doi.org/10.1002/cncr.33918
HART, Michael G.; GARSIDE, Ruth; ROGERS, Gabriel; STEIN, Ken; GRANT, Robin. Temozolomide for high grade glioma. Cochrane Database of Systematic Reviews, [S. l.], v. 2013, n. 4, 2013 DOI: https://doi.org/10.1002/14651858.CD007415.pub2
HEEMANN, Gabriel Carvalho; HEEMANN, Antônio Carlos Cunha. Glioblastoma multiforme recém-diagnosticado: diagnóstico e tratamento cirúrgico inicial. Acta méd. (Porto Alegre), [S. l.], p. 163–172, 2018.
JANJUA, Taskeen Iqbal et al. Frontiers in the treatment of glioblastoma: Past, present and emerging. Advanced Drug Delivery Reviews, [S. l.], v. 171, p. 108–138, 2021. DOI: https://doi.org/10.1016/j.addr.2021.01.012 Disponível em: https://www.sciencedirect.com/science/article/pii/S0169409X21000223
PARPURA, Vladimir et al. Glial cells in (patho)physiology. Journal of Neurochemistry, [S. l.], v. 121, n. 1, p. 4–27, 2012 DOI: https://doi.org/10.1111/j.1471-4159.2012.07664.x
RODRÍGUEZ-CAMACHO, Alejandro et al. Glioblastoma Treatment: State-of-the-Art and Future Perspectives. International Journal of Molecular Sciences, [S. l.], v. 23, n. 13, p. 1–35, 2022 DOI: https://doi.org/10.3390/ijms23137207
SPLITTGERBER, Ryan. Snell Neuroanatomia Clínica. Brasil: Grupo GEN, 2021. E-book. ISBN 9788527737913.
VILELA, Manuel Augusto Pereira e HACKBART, Aline de Araújo. Oncologia básica: experiência multidisciplinar da UFPel. - Pelotas: Editora Universitária UFPel, 2008. 404 p. : il. 4
WIRSCHING, Hans Georg; GALANIS, Evanthia; WELLER, Michael. Glioblastoma. Handbook of Clinical Neurology, [S. l.], v. 134, p. 381–397, 2016 DOI: https://doi.org/10.1016/B978-0-12-802997-8.00023-2
WU, Wei; KLOCKOW, Jessica L.; ZHANG, Michael; LAFORTUNE, Famyrah; CHANG, Edwin; JIN, Linchun; WU, Yang; DALDRUP-LINK, Heike E. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacological Research, [S. l.], v. 171, n. May, p. 105780, 2021. Disponível em: https://doi.org/10.1016/j.phrs.2021.105780 DOI: https://doi.org/10.1016/j.phrs.2021.105780
Licença
Copyright (c) 2023 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.